Today, I’m eager to share updates on three of our model portfolio companies: an “Imperium” DNA science company, a disruptive pharmaceutical business and a renewable-energy grid enabler.
Read MoreI dig into what exactly the company does, explaining the problems that Evogene is seeking to address — as well as its innovative solutions.
Read MoreI reached out in a trade alert yesterday to advise selling two of our stocks…
Read MoreStock highlights: TWST, STEM, HEAR, CSIQ, INT, IIIN, IBKR, WIT & AQB. (33-minute video) In the August edition of our portfolio update, I address the stocks that are most on your mind right now, at least based on the feedback you’ve sent to my team and me.
Read MoreI’m a firm believer in the power of modern medicine — and the massive growth the industry will experience in the decades ahead.
Read More
Enter your username and password below